Position in ABBV
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$248,953,843
+$2,725,479 QoQ
Shares Held
1,144,668
+6.2% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
1.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Candriam S.C.A. holds $1,534,786,576 across 9 Drug Manufacturers - General names. ABBV ranks #2 (16.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
417,282 | $383,803,465 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
1,144,668 | $248,953,843 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
1,670,288 | $232,788,038 | |
| 4 | JNJ |
Johnson & Johnson
|
798,815 | $195,262,338 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,322,654 | $159,102,049 | |
| 6 | AMGN |
Amgen Inc
|
395,351 | $139,104,249 | |
| 7 | BIIB |
Biogen Inc.
|
381,768 | $69,989,527 | |
| 8 | PFE |
Pfizer Inc
|
1,992,586 | $55,951,814 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $248,953,843 | 1,144,668 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $246,228,364 | 1,077,633 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $193,501,682 | 835,716 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $106,878,511 | 575,792 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $84,121,860 | 401,498 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $73,716,712 | 414,838 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $76,468,600 | 387,222 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $39,875,141 | 232,481 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $44,520,900 | 244,486 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $34,194,440 | 220,652 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $31,572,845 | 211,813 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $28,991,875 | 215,185 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $31,814,076 | 199,624 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $40,430,943 | 250,176 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $42,957,668 | 320,078 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $50,818,641 | 331,801 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $58,333,337 | 359,838 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $46,422,837 | 342,857 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $37,839,393 | 350,787 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $39,633,059 | 351,856 | Shares | Other | 2021-07-20 | |
| 2021-03-31 | $57,365,365 | 530,081 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $56,796,679 | 530,067 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $58,318,122 | 665,808 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $65,149,302 | 663,570 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $56,534,579 | 742,021 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||